POLUS: Description of the Effectiveness and Tolerability of Luseogliflozin in Patients With Type 2 Diabetes.
Clinical trial NCT07433192 · RECRUITING
Trial details
- NCT number
- NCT07433192
- Sponsor
- Servier Russia
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-03-02
- Primary completion
- 2027-03-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.